Clinical Trial Update: Impact of Black Seed Oil on Hemodialysis Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the impact of black seed oil on patients with end-stage renal disease undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Black seed oil (Nigella sativa oil)

Snippet

Sponsor: Ain Shams University | Conditions: End Stage Renal Disease | Phase 2 | Status: UNKNOWN